These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20099117)

  • 1. Immunology of vaccine adjuvants.
    Ribeiro CM; Schijns VE
    Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The perfect mix: recent progress in adjuvant research.
    Guy B
    Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine immunopotentiators of the future.
    Schijns VE; Degen WG
    Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and direction of immune responses by vaccine adjuvants.
    Schijns VE
    Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adjuvant technology: from mechanistic concepts to practical applications.
    Degen WG; Jansen T; Schijns VE
    Expert Rev Vaccines; 2003 Apr; 2(2):327-35. PubMed ID: 12899582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches.
    Schijns VE; Tangerås A
    Dev Biol (Basel); 2005; 121():127-34. PubMed ID: 15962475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of vaccine design-Lessons from nature.
    Zepp F
    Vaccine; 2010 Aug; 28 Suppl 3():C14-24. PubMed ID: 20713252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New horizons in adjuvants for vaccine development.
    Reed SG; Bertholet S; Coler RN; Friede M
    Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart adjuvants.
    Schmidt CS; Morrow WJ; Sheikh NA
    Expert Rev Vaccines; 2007 Jun; 6(3):391-400. PubMed ID: 17542754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starch microparticles as vaccine adjuvant.
    Rydell N; Stertman L; Sjöholm I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.